The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Estrogen receptor and breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
(2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01458-13 · Cited by 364
RetractedThe Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Haagenson, C. (1971) · Cited by 1,773
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
(1991) · PubMed · Cited by 1,101
Pike, A. C. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4608 · Cited by 986
Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.
Picard, D., & Yamamoto, K. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02654.x · Cited by 970
Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression
Laherty, C. D., Yang, W.-M., Sun, J.-M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997) · Cell · doi:10.1016/s0092-8674(00)80215-9 · Cited by 938
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660
Proteasome-dependent degradation of the human estrogen receptor
Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1858 · Cited by 589
Hormone-Dependent Coactivator Binding to a Hydrophobic Cleft on Nuclear Receptors
Feng, W., Ribeiro, R. C. J., Wagner, R. L., Nguyen, H., Apriletti, J. W., Fletterick, R. J., Baxter, J. D., Kushner, P. J., & West, B. L. (1998) · Science · doi:10.1126/science.280.5370.1747 · Cited by 580
Gordon, D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92329-1 · Cited by 552
Voegel, J. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.507 · Cited by 515
Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Dauvois, S., Danielian, P. S., White, R., & Parker, M. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4037 · Cited by 465
Aronica, S. M. (1993) · Molecular Endocrinology · doi:10.1210/me.7.6.743 · Cited by 456
Le Goff, P., Montano, M. M., Schodin, D. J., & Katzenellenbogen, B. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41801-1 · Cited by 452
Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1182 · Cited by 452
Klein-Hitpass, L., Ryffel, G. U., Heitlinger, E., & Cato, A. C. B. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.2.647 · Cited by 429
Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A., & Moore, D. D. (1995) · Nature · doi:10.1038/374091a0 · Cited by 425
Fisher, B., Redmond, C., Fisher, E. R., & Caplan, R. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.7.1076 · Cited by 419
Ito, M., Yuan, C.-X., Malik, S., Gu, W., Fondell, J. D., Yamamura, S., Fu, Z.-Y., Zhang, X., Qin, J., & Roeder, R. G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80463-3 · Cited by 419
Onate, S. A., Boonyaratanakornkit, V., Spencer, T. E., Tsai, S. Y., Tsai, M.-J., Edwards, D. P., & O'Malley, B. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12101 · Cited by 417
ICI 182,780 (Faslodex?): Development of a novel, ?pure? antiestrogen
Howell, A., Osborne, C. K., Morris, C., & Wakeling, A. E. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4<817::aid-cncr14>3.0.co;2-6 · Cited by 408
McKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405
p300 is a component of an estrogen receptor coactivator complex.
Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., & Brown, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11540 · Cited by 396
Webb, P. M., Nguyen, P. T., Valentine, C. D., Lopez, G. N., Kwok, G. R., McInerney, E. M., Katzenellenbogen, B. S., Enmark, E., Gustafsson, J.-Α., Nilsson, S. V., et al. (1999) · Molecular Endocrinology · doi:10.1210/me.13.10.1672 · Cited by 396
The histone acetylase PCAF is a nuclear receptor coactivator
Blanco, J. C. G., Minucci, S., Lu, J., Yang, X.-J., Walker, K. K., Chen, H., Evans, R. M., Nakatani, Y., & Ozato, K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1638 · Cited by 388
Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., & Isola, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2584 · Cited by 358
Ferguson, A. T., Lapidus, R. G., Baylin, S. B., & Davidson, N. E. (1995) · PubMed · Cited by 297
Montano, M. M., Ekena, K., Delage-Mourroux, R., Chang, W., Martini, P., & Katzenellenbogen, B. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6947 · Cited by 296
Mechanism of estrogen activation of c-myc oncogene expression.
Dubik, D., & Shiu, R. P. C. (1992) · PubMed · Cited by 294
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 291
Self-citationA hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua, S. A. W., Wiltschke, C., ZHANG, Q. X., Borg, Å., Castles, C. G., Friedrichs, W. E., Hopp, T., Hilsenbeck, S. G., Mohsin, S. K., O'Connell, P., et al. (2000) · PubMed · Cited by 278
Self-citationRoodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Huang, N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3398 · Cited by 262
THE NUCLEAR HORMONE RECEPTOR GENE SUPERFAMILY
Ribeiro, M. D., Kushner, P. D., & Baxter, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.443 · Cited by 260
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
Tip60 Is a Nuclear Hormone Receptor Coactivator
Brady, M. E., Ozanne, D. M., Gaughan, L., Waite, I., Cook, S., Neal, D. E., & Robson, C. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17599 · Cited by 255
Lapidus, R. G., Ferguson, A. T., Ottaviano, Y. L., Parl, F. F., Smith, H. S., Weitzman, S. A., Baylin, S. B., Issa, J. J., & Davidson, N. E. (1996) · PubMed · Cited by 250
Montano, M. M. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.814 · Cited by 246
Weis, K. E. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1388 · Cited by 236
A Regulatory Role for RIP140 in Nuclear Receptor Activation
Treuter, E. (1998) · Molecular Endocrinology · doi:10.1210/me.12.6.864 · Cited by 230
McInerney, E. M., & Katzenellenbogen, B. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24172 · Cited by 222
Henttu, P. M. A., Kalkhoven, E., & Parker, M. G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1832 · Cited by 213
Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik, P. S., Kulkarni, S., Liu, X.-P., Budd, G. T., & Bukowski, R. M. (1994) · PubMed · Cited by 192
Chambraud, B., Berry, M., Redeuilh, G., Chambon, P., & Baulieu, E. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30558-6 · Cited by 189
Zhu, Y., Qi, C., Jain, S., Le Beau, M. M., Espinosa, R., Atkins, G. B., Lazar, M. A., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10848 · Cited by 165
Labrie, F., Labrie, C., Bélanger, A., Simard, J., Gauthier, S., Luu-The, V., Mérand, Y., Giguere, V., Candas, B., Luo, S., et al. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00065-5 · Cited by 163
Imhof, M. O., & McDonnell, D. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2594 · Cited by 160
Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
Ichinose, H., Garnier, J.-M., Chambon, P., & Losson, R. (1997) · Gene · doi:10.1016/s0378-1119(96)00785-8 · Cited by 159
Antiestrogens – Tamoxifen, SERMs and Beyond
Dhingra, K. (1999) · Investigational New Drugs · doi:10.1023/a:1006348907994 · Cited by 148
Alen, P., Claessens, F., Schoenmakers, E., Swinnen, J. V., Verhoeven, G., Rombauts, W., & Peeters, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0214 · Cited by 141
RAP46 Is a Negative Regulator of Glucocorticoid Receptor Action and Hormone-induced Apoptosis
Kullmann, M. K., Schneikert, J., Moll, J., Heck, S., Zeiner, M., Gehring, U., & Cato, A. C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14620 · Cited by 140
The oestrogen receptor regulates NFκB and AP-1 activity in a cell-specific manner
Cerillo, G., Rees, A., Manchanda, N., Reilly, C., Brogan, I. J., White, A. E., & Needham, M. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00078-8 · Cited by 134
Muscat, G. E. O., Burke, L. J., & Downes, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.12.2899 · Cited by 125
Qin, C., Singh, P., & Safe, S. H. (1999) · Endocrinology · doi:10.1210/endo.140.6.6751 · Cited by 120
Identification of a Third Autonomous Activation Domain within the Human Estrogen Receptor
Norris, J. D., Fan, D., Kerner, S. A., & McDonnell, D. P. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0008 · Cited by 113
Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140
Peters, G. A., & Khan, S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0244 · Cited by 112
Thénot, S., Henriquet, C., Rochefort, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12062 · Cited by 111
Enhancement of human estrogen receptor activity by SPT6: a potential coactivator
Baniahmad, C., Nawaz, Z., Baniahmad, A., Gleeson, M. A., Tsai, M., & O’Malley, B. W. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.1.7760849 · Cited by 105
Identification of a negative regulatory function for steroid receptors.
McDonnell, D. P., Vegeto, E., & O'Malley, B. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10563 · Cited by 102
Montano, M. M., Ekena, K., Krueger, K. D., Keller, A. L., & Katzenellenbogen, B. S. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.3.8833652 · Cited by 93
Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor
Fuchs‐Young, R., GLASEBROOK, A. L., Short, L. L., Draper, M. W., Rippy, M. K., Cole, H. W., Magee, D. E., Termine, J. D., & Bryant, H. U. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31392.x · Cited by 86
Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.
Weigel, R. J., & deConinck, E. C. (1993) · PubMed · Cited by 83
Novel compounds inhibit estrogen formation and action.
Labrie, C., Martel, C., Dufour, J. M., Lévesque, C., Mérand, Y., & Labrie, F. (1992) · PubMed · Cited by 74
Hopp, T. A., & Fuqua, S. A. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018726418931 · Cited by 65
Self-citationChan, C. M. W., Lykkesfeldt, A. E., Parker, M. G., & Dowsett, M. (1999) · PubMed · Cited by 56
Neurotransmitters activate the human estrogen receptor in a neuroblastoma cell line
Gangolli, E. A., Conneely, O. M., & O’Malley, B. W. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00003-4 · Cited by 52
Simon, S. L., Parkes, A., Leygue, E., Dotzlaw, H., Snell, L., Troup, S., Adeyinka, A., Watson, P. H., & Murphy, L. C. (2000) · PubMed · doi:10.7907/rgmw-4b58 · Cited by 46
Effect of antioestrogens on the DNA binding activity of oestrogen receptorsin vitro
Arbuckle, N. D., Dauvois, S., & Parker, M. G. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.15.3839 · Cited by 43
Development of peptide antagonists that target estrogen receptor–cofactor interactions
McDonnell, D. P., Chang, C., & Norris, J. D. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00109-6 · Cited by 39
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells.
Auricchio, F., Domenico, M. D., Migliaccio, A., Castoria, G., & Bilancio, A. (1995) · PubMed · Cited by 34
Sabbah, M., Kwang-Il, K. A. N. G., Tora, L., & Redeuilh, G. (1998) · Biochemical Journal · doi:10.1042/bj3360639 · Cited by 34
Cited by
Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., & Leitman, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2446 · Cited by 576
MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer
Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., & Wade, P. A. (2003) · Cell · doi:10.1016/s0092-8674(03)00234-4 · Cited by 510
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 424
Metadata
- Authors
- Sommer, S., & Fuqua, S. A. W.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 11
- Issue
- 5
- Pages
- 339-352
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2015629450
- Cited by
- 355
- References
- 82
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.